Significant quantitative and qualitative changes were observed in the excretion of uromodulin in patients with AFD, that is, a gradual decrease in excretion accompanied in some cases by an aberrant uromodulin without the C-terminal part after the K432 residue. This evidence concerns the gene UMOD and Nager acrofacial dysostosis.